Search results
Results from the WOW.Com Content Network
Avian influenza, also known as avian flu or bird flu, is a disease caused by the influenza A virus, which primarily affects birds but can sometimes affect mammals including humans. [1] Wild aquatic birds are the primary host of the influenza A virus, which is enzootic (continually present) in many bird populations.
In November 2013, the U.S. Food and Drug Administration (FDA) approved an experimental H5N1 bird flu vaccine to be held in stockpiles. [22] [23] In a clinical trial including 3,400 adults, 91% of people age 18–64 and 74% of people age 65 or older formed an immune response sufficient to provide protection. Reported adverse effects were ...
A bird-adapted strain of H5N1, called HPAI A(H5N1) for "highly pathogenic avian influenza virus of type A of subtype H5N1", is the causative agent of H5N1 flu. HPAI A(H5N1) is considered an avian disease, although there is some evidence of limited human-to-human transmission of the virus. [2] A risk factor for contracting the virus is handling ...
The World Health Organization does not currently list the bird flu outbreak as a global health emergency. ... one of the primary medications used to treat ordinary cases of influenza.
Bird flu, a.k.a. H5N1, has dominated headlines in the U.S. for months.But while this illness is known worldwide for having a high mortality rate, the vast majority of infections in America have ...
What we think of as the seasonal flu in humans is caused by types A and B. Bird flu falls under the umbrella of influenza A viruses. The strain currently spreading in the U.S. is H5N1, an HPAI ...
List of Antiviral Drugs Antiviral Use Manufacturer Component Type Year approved Abacavir: HIV: ViiV Healthcare: Nucleoside analogue reverse transcriptase inhibitor (NRTI) 1998 Acyclovir (Aciclovir) Herpes Simplex, chickenpox, [2] varicella zoster virus: GSK: guanosine analogue RTI 1981 Adefovir: Hepatitis B [3] Gilead Sciences RTI 2002 , 2003 ...
Targets of anti-influenza agents that are licensed or under investigation. Vaccines and drugs are available for the prophylaxis and treatment of influenza virus infections. Vaccines are composed of either inactivated or live attenuated virions of the H1N1 and H3N2 human influenza A viruses, as well as those of influenza B viruses.